Zydus Lifesciences receives tentative USFDA approval for Olaparib Tablets (100mg, 150mg) used in treating BRCA-related ovarian, breast, pancreatic, and prostate cancers.
Alembic Pharmaceuticals Limited (Alembic), a pharmaceutical company engaged in vertically integrated research and development, has announced that it has obtained final approval from the US Food & Drug Administration (FDA) for its Abbreviated New Drug
Bayer’s Kerendia™ (finerenone) approved in India for HFpEF/HFmrEF, offering dual heart-kidney protection and improving outcomes in high-risk cardiovascular patients.
Zydus Lifesciences Ltd. is set to broaden its US specialty sector with non-core molecules composition Saroglitazar. The company has a plan to use the funds from its recently approved ?5,000-crore Qualified Institutional Placement
Apollo Hospitals Enterprise Ltd. (AHEL) has demonstrated strong financial performance in the second quarter of FY26 with a 13% year-on-year (YoY) revenue increase to Rs 6,304 crore along with a 26% surge in consolidated profit
In order to guarantee that innovative tuberculosis (TB) vaccines reach adults and adolescents in high-burden nations, a new WHO report that was released on the fringes of the G20 Health Ministers Meeting in Limpopo, South Africa, argues for daring
Marksans Pharma Limited has announced that its wholly owned subsidiary in the United Kingdom, Relonchem Limited, has obtained Marketing Authorization from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for its product Exemestane 2
The latest portable ultrasound device, Sonosite MT, by FUJIFILM Sonosite, is the addition to the point-of-care product range, PX, LX, and the ST. The stand provides clinicians with flexibility as the clamshell-like MT can be utilized with or...
In a moment that transcended medical victory, Ujwala Chavan, a 37-year-old from Mumbai, recently sat down to a simple, solid meal; an act most take for granted, but one she had been waiting 14 years to experience...
For the first time, Sun Pharmaceutical has seen its U.S. sales of innovative medicines overtake generics in the second quarter of FY26, marking a major shift for India’s largest drug maker. The surge came on the back of strong sales of Ilumya...
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")